Biotechblog – Page 1077 – Biotechnology business, policy, and more!

Perspectives on the Kyoto Prize

This is my initial response to the Kyoto Prize, which I was able to attend on a fellowship from Point […]

At a recent event on the comparative advantages of small molecule vs. biologic drugs, several themes emerged which led me

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s

DCbiotech is a high-level networking group based in Washington DC. The objective is to bring together individuals working in, or

DCbiotech is a high-level networking group based in Washington DC. The objective is to bring together individuals working in, or

With two life science IPOs earlier this month, and seemingly fewer stories of biotechnology firm liquidations, it seems that the